Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tc 99m tilmanocept imaging in Kaposi's Sarcoma
NCT02201420Phase 2Completed
- Sponsor
- Navidea Biopharmaceuticals, Inc.
- Start
- Sep 2014
- Primary completion
- Mar 2015
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of technetium tc 99m tilmanocept in Kaposi's sarcoma (KS), sponsored by Navidea Biopharmaceuticals, Inc.. Started Sep 2014; status: completed.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
Kaposi's sarcoma (KS)
Beyond the preview
Go deeper on NCT02201420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201420.